NewGenIvf Group Ltd

Análisis de la acción NewGenIvf Group Ltd (NIVF)

$0.450

-0.034 (-7.61%)Al cierre

Loading chart…
Máximo
0.493
Apertura
0.493
Precio medio ponderado por volumen
0.46
Volumen
78.02K
Capitalización
—
Mínimo
0.450
Importe
36.22K
EV/EBITDA, TTM
-0.02

NewGenIVF Group Limited is a diversified healthcare and technology-driven platform focused on investments across fertility services, consumer wellness, digital assets, and real estate. The Company operates through three business divisions, which include NewGenProperty, which operates real estate development projects in the United Arab Emirates (UAE)'s Ras Al Khaimah Emirate; NewGenDigital, which serves as the Company's digital asset and decentralized finance (DeFi) solutions arm, and NewGenSup, which focuses on health and longevity products and solutions. Its legacy business involves providing in-vitro fertilization (IVF) and assisted reproductive treatment services, such as surrogacy and egg freezing across Asia.

newgenivf.com

Análisis de IA of NewGenIvf Group Ltd (NIVF)

Vender

NIVF is not a good buy right now due to its extremely low price of $0.45, a staggering year-to-date change of -99.98%, and a very low RSI of 15.207, indicating oversold conditions. The stock has also seen a 5-day change of -54.06%, suggesting a strong downward trend. The main risk is the company's recent public offering, which has caused further declines in stock price, and the uncertainty surrounding its financial stability, as evidenced by a forward P/E of 0.0015, indicating potential earnings issues.

Métricas de valoración

El PER previsto actual de NewGenIvf Group Ltd (NIVF) es 0.00, frente a su media de 5 años de 0.07.

PER previsto

Valor razonable
Media 5A P/E
0.07
P/E actual
0.00
Sobrevalorada
0.30
Infravalorada
-0.16

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
-0.22
EV/EBITDA actual
-0.02
Sobrevalorada
0.59
Infravalorada
-1.03

Precio/ventas previsto

Sobrevalorado
Media 5A P/S
0.01
P/S actual
0.03
Sobrevalorada
0.02
Infravalorada
-0.01

Escenarios de precio de Alphio AI para NIVF

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%NIVF

$0.57

Precio del escenario

B

Base

Base · 50%NIVF

$0.57

Precio del escenario

B

Bajista

Bajista · 25%NIVF

$0.56

Precio del escenario

Cronología de eventos

2026-10-27 (ET)

09:30:00

NewGenIvf Group Files $100M Mixed Securities Shelf

2026-10-22 (ET)

20:00:00

NewGenIvf Group Ltd Trading Halted, News Pending

2026-10-09 (ET)

20:00:00

NewGenIvf Group Ltd Trading Halted, News Pending

2026-09-29 (ET)

06:30:00

NewGenIvf Group Prices Public Offering at $1.25M

2026-08-31 (ET)

20:00:00

NewGenIvf Group Ltd Trading Halted, News Pending

Noticias

Preguntas frecuentes sobre NIVF, respondidas por Alphio AI

NewGenIVF Group Limited is a diversified healthcare and technology-driven platform focused on investments across fertility services, consumer wellness, digital assets, and real estate. The Company operates through three business divisions, which include NewGenProperty, which operates real estate development projects in the United Arab Emirates (UAE)'s Ras Al Khaimah Emirate; NewGenDigital, which serves as the Company's digital asset and decentralized finance (DeFi) solutions arm, and NewGenSup, which focuses on health and longevity products and solutions. Its legacy business involves providing in-vitro fertilization (IVF) and assisted reproductive treatment services, such as surrogacy and egg freezing across Asia. It operates in the Healthcare sector.

NIVF is not a good buy right now due to its extremely low price of $0.45, a staggering year-to-date change of -99.98%, and a very low RSI of 15.207, indicating oversold conditions. The stock has also seen a 5-day change of -54.06%, suggesting a strong downward trend. The main risk is the company's recent public offering, which has caused further declines in stock price, and the uncertainty surrounding its financial stability, as evidenced by a forward P/E of 0.0015, indicating potential earnings issues.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar